ACHFF (Arch Biopartners) Cyclically Adjusted Book per Share: $-0.04 (As of Mar. 2026)


ACHFF Arch Biopartners Inc ACHFF
26 GF Score
Price $0.64
! 4 Warning Signs
View Full Analysis

What is Arch Biopartners Cyclically Adjusted Book per Share?

Arch Biopartners ACHFF +5.30% 26 Cyclically Adjusted Book per Share is $-0.04 as of Mar. 2026. GuruFocus rates ACHFF with a GF Score™ of 26/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Arch Biopartners's adjusted book value per share for the three months ended in Mar. 2026 was $-0.039. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-0.04 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -26.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -40.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -15.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Arch Biopartners was 20.60% per year. The lowest was -58.70% per year. And the median was -26.00% per year.

As of today (2026-06-28), Arch Biopartners's current stock price is $0.6423. Arch Biopartners's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $-0.04. Arch Biopartners's Cyclically Adjusted PB Ratio of today is .


Arch Biopartners  (OTCPK:ACHFF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Arch Biopartners Cyclically Adjusted Book per Share Related Terms


Arch Biopartners Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Arch Biopartners's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Biopartners Cyclically Adjusted Book per Share Chart

Arch Biopartners Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.02 -0.03 -0.04 -0.04

Arch Biopartners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.04 -0.04 -0.04 -0.04

ACHFF vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Arch Biopartners's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arch Biopartners Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's Cyclically Adjusted PB Ratio falls into.


ACHFF
26GF Score
Arch Biopartners Inc ACHFF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Biopartners Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arch Biopartners's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.039/132.2623*132.2623
=-0.039

Current CPI (Mar. 2026) = 132.2623.

Arch Biopartners Quarterly Data

Book Value per Share CPI Adj_Book
201606 -0.001 102.002 -0.001
201609 -0.004 101.765 -0.005
201612 -0.007 101.449 -0.009
201703 -0.003 102.634 -0.004
201706 -0.007 103.029 -0.009
201709 -0.008 103.345 -0.010
201712 -0.013 103.345 -0.017
201803 -0.003 105.004 -0.004
201806 -0.004 105.557 -0.005
201809 -0.011 105.636 -0.014
201812 -0.023 105.399 -0.029
201903 -0.029 106.979 -0.036
201906 -0.029 107.690 -0.036
201909 -0.034 107.611 -0.042
201912 -0.045 107.769 -0.055
202003 -0.041 107.927 -0.050
202006 -0.032 108.401 -0.039
202009 -0.048 108.164 -0.059
202012 -0.061 108.559 -0.074
202103 -0.074 110.298 -0.089
202106 -0.064 111.720 -0.076
202109 -0.049 112.905 -0.057
202112 -0.051 113.774 -0.059
202203 -0.050 117.646 -0.056
202206 -0.050 120.806 -0.055
202209 -0.054 120.648 -0.059
202212 -0.053 120.964 -0.058
202303 -0.064 122.702 -0.069
202306 -0.069 124.203 -0.073
202309 -0.065 125.230 -0.069
202312 -0.068 125.072 -0.072
202403 -0.076 126.258 -0.080
202406 -0.074 127.522 -0.077
202409 -0.050 127.285 -0.052
202412 -0.046 127.364 -0.048
202503 -0.040 129.181 -0.041
202506 -0.040 129.892 -0.041
202509 -0.042 130.287 -0.043
202512 -0.039 130.366 -0.040
202603 -0.039 132.262 -0.039

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $-0.04 mean?
Arch Biopartners (ACHFF) has a Cyclically Adjusted Book per Share of $-0.04 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Arch Biopartners and its competitors.
Is Arch Biopartners' Cyclically Adjusted Book per Share too high?
Arch Biopartners' current Cyclically Adjusted Book per Share is $-0.04. Overall, Arch Biopartners has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Arch Biopartners' Cyclically Adjusted Book per Share compare to VRTX and REGN?
Arch Biopartners' Cyclically Adjusted Book per Share of $-0.04 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Arch Biopartners and its competitors. Arch Biopartners's current Cyclically Adjusted Book per Share is $-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Biopartners stock overvalued right now?
Arch Biopartners (ACHFF) has a current Cyclically Adjusted Book per Share of $-0.04. The current Cyclically Adjusted Book per Share is $-0.04. Arch Biopartners' overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Arch Biopartners (ACHFF), the current Cyclically Adjusted Book per Share is $-0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Biopartners Business Description

Other Exchanges 8HA:GermanyARCH:Canada
Address 545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
26GF Score

Get the complete analysis for ACHFF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.64
Price